Healthcare
Research Fellow from German Research Center for Artificial Intelligence to lead team driving solutions for pharmaceutical partners
Pharma and biotechs from across the globe share news, pipeline updates, with stories from Vetter, Atomwise, Tessa, GenSight, and more.
PureTech, which has headquarters in Boston, but is listed in London, signed a research collaboration deal with Germany’s Boehringer Ingelheim. The companies will work to develop novel product candidates using PureTech’s proprietary lymphatic targeting technology for immune modulation.
The life science industry is continually making advancements in every area! We want to know what cool science innovations are currently in progress and the professionals behind them.
Developing a Human Factors Validation Plan with Consideration for the Digital Health Marketplace
Combining genetic and biochemical testing to provide the most comprehensive screening for rare metabolic conditions
Getinge’s Maquet PowerLED II Surgical Light brings best in class technology to general and Hybrid OR’s by improving surgical efficiency for surgeons and staff.
Repairing a damaged organ in order to allow an individual to have a healthier life, as well as a greater quality of life, could soon be a reality as New York-based Angion Biomedica Corp. moves toward completing clinical trials of its lead asset.
San Francisco-based Audentes Therapeutics signed a licensing agreement and collaboration deal with Nationwide Children’s Hospital to expand its pipeline for vectorized antisense treatments for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1).
The recent CBRE Research report, “2019 U.S. Life Sciences Clusters” has two Texas metropolitan areas in its top-10 fastest-growing life sciences market. Houston ranked third, while Dallas/Ft. Worth ranked seventh. Let’s look at Dallas/Ft. Worth.
PRESS RELEASES